A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine

Journal of Natural Science, Biology and Medicine

Volumn 2, Issue 2, 2011, Pages 168-173

  Kumar, Rajnish ^a,b   Sharma, Anju ^a,b   Varadwaj, Pritish Kumar ^a  

^a INDIAN INSTITUTE OF INFORMATION TECHNOLOGY   (India)

^b AMITY UNIVERSITY   (India)

Author keywords

Drugs; Machine learning; Oral bioavailability; Prediction; Support vector machine

Indexed keywords

EID: 84878744355     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.92325     Document Type: Article

References (47)

1. Moda TL, Montanari CA, Andricopulo AD. Hologram QSAR model for the prediction of human oral bioavailability. Bioorg Med Chem 2007;15:7738-45.
2. Waterbeemd H, Gifford E. ADMET in silico modeling: Towards prediction paradise? Nat Rev Drug Disc 2003;2:192-204.
3. Van de Waterbeemd H, Rose S. In The Practice of Medicinal Chemistry. 2nd ed. In: Wermuth LG, editor. Academic Press; 2003. p. 1367-85.
4. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-23.
5. Masoud J, Dabid T, Jiansong Y, Sibylle N, Sebastian P, Amin RH, et al. Population based mechanistic prediction of oral drug absorption. AAPS J 2009;11:225-37.
6. Stephen RJ, Weifan Z. Recent progress in the computational prediction of aqueous solubility and absorption. AAPS J 2006;8: E27-40.
7. Lipsinki CA, Lomabardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 2001;46:3-26.
8. Manuel AN, Pravin RC. Design principles for orally bioavailable drugs. Drug Discov Today 1999;1:179-89.
9. Hirschmann R. Peptide research a means to further biological and chemical understanding. In Peptides 1996. Proceedings of the 24th European peptide Symposium.
10. Martin TK, Yvonne A. Influence of molecular properties on oral bioavailability of lipophilic drugs-Mapping of bulkiness and different measures of polarity. Pharm Dev Technol 2009;14:312-20.
11. Lu JJ, Crimin K, Goodwin JT, Crivori P, Orrenius C, Xing L, et al. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. J Med Chem 2004;47:6104-7.
12. Martin YC. A bioavailability score. J Med Chem 2005;48:3164-70.
13. Vieth M, Siegel MG, Higgs RE, Watson IA, Robertson DH, Savin KA, et al. Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem 2004;47:224-32.
14. Sietsema WK. The absolute oral bioavailability of selected drugs. Int J Clin Pharmacol Ther Toxicol 2000;44:235-49.
15. Hou T, Wang J, Zhang W, Xu X. ADME evaluation in Drug Discovery.6. Can Oral bioavailability in humans be predicted by simple molecular property-based rules. J Chem Inf Model 2007;47:460-3.
16. Somogyi A, Eichelbaum M, Gugler R. Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data. Eur J Clin Pharm 2006;22:85-90.
17. Usansky HH, Sinko PJ. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: Model development and evaluation and derivation of analytical solutions for k(a) and F(a). J Pharmacol Exp Ther 2005;314:391-9.
18. Mahmood I. Prediction of absolute bioavailability for drugs using oral and renal clearance following a single dose: A critical view. Biopharm and Drug Dispos 1997;18:465-73.
19. Obata K, Sugano K, Saitoh R, Hiqashida A, Nabuchi Y, Machida M, et al. Prediction of oral drug absorption in humans by theoretical passive absorption model. Int J Pharm 2005;293:183-92.
20. Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB. A physiological model for the estimation of the fraction dose absorbed in humans. J Med Chem 2004;47:4022-31.
21. Arun KM, Thomas NT, Hwang KK. Graphical model for estimating oral bioavailability of drugs in humans and other species from there Caco-2 permeability and in vitro liver enzyme metabolic stability rates. J Med Chem 2002;45:304-11.
22. Yoshida F, Topliss JG. QSAR model for drug human oral bioavailability. J Med Chem 2000;43:2575-85.
23. Podlogar BL, Muegge I, Brice LJ. Computational methods to estimate drug development parameters. Curr Opin Drug Disc Dev 2001;4:102-9.
24. Andrews CW, Bennett L, Yu LX. Predicting human oral bioavailability of a compound: Development of a novel quantitative structurebioavailability relationship. Pharm Res 2000;17:639-44.
25. Bai JP, Utis A, Crippen G, He HD, Fischer V, Tullman R, et al. Use of classification regression tree in predicting oral absorption in humans. J Chem Inf Comput Sci 2004;44:2061-9.
26. Zmuidinavicius D, Didziapetris R, Japertas P, Avdeef A, Petrauskas A. Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption. J Pharm Sci 2003;92:621-33.
27. Joseph VT, Beverly DG, Snezana AK. Prediction of drug bioavailability based on molecular structure. Anal Chimica Acta 2003;485:89-102.
28. Klopman G, Stefan LR, Saiakhov RD. ADME evaluation, II: A computer model for the prediction of intestinal absorption in humans. Eur J Pharm Sci 2002;17:253-63.
29. Francesco A, Stefano L, Enza M, Leonardo V. Genetic programming for human bioavailability of drugs. GECCO'06 2006. p. 255-62.
30. Sara S, Leonardo V. Operator equalization, bloat and overfitting: A study on humab bioavailability prediction. ACM 2009. p. 1115-22.
31. Bains W, Gilbert R, Sviridenko L, Gascon JM, Scoffin R, Birchall K, et al. Evolutionary computational methods to predict oral bioavailability QSPRs. Curr Opin Drug Disc Dev 2002;5:44-51.
32. Wang J, Krudy G, Xie XQ, Wu C, Holland G. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion. J Chem Inf Model 2006;46:2674-83.
33. Pintore M, Van de Waterbeemd H, Piclin N, Chrétien Jr. Prediction of oral bioavailability by adaptive fuzzy partitioning. Eur J Med Chem 2003;38:427-31.
34. Turner JV, Maddalena DJ, Agatonovic-Kustrin S. Bioavailability prediction based on molecular structure for a diverse series of drugs. Pharm Res 2004;21:68-82.
35. Fröhlich H, Sieker F, Wegner K, Zell A. Kernel functions for attributed molecular graphs - a new similarity based approach to ADME prediction in classification and regression. QSAR Comb Sci 2005;25:317-26.
36. Liu HX, Hu RJ, Zhang RS, Yao XJ, Liu MC, Hu ZD, et al. The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine. J Comput Aided Mol Des 2005;19:33-46.
37. Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, et al. Rate limited steps of human oral absorption and QSAR studies. Pharmaceut Res 2002;19:1446-57.
38. Oprea I, Gottfries J. Toward minimalistic modeling of oral drug absorption. J Mol Graphics Modell 1999;17:261-74.
39. Kenneth ET, Danny DS. Percentage oral availability. Book: Goodman and Gilman's The Pharmacological Basis of Therapeutics". 10/e, ed. In: Hardman JG, Limbird LE, Gilman AG, editors. McGraw-Hill, p. 1917-2023.
40. Dorronsoro I, Chana A, Abasolo MI, Castro A, Gil C, Stud M, et al. CODES/neural network model: A useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugs. QSAR Comb Sci 2004;23:89-98.
41. Linnankoski J, Makela JM, Ranta VP, Urtti A, Yliperttula M. Computational prediction of oral drug absorption based on absorption rate constants in humans. J Med Chem 2006;49:3674-81.
42. Sharma A, Kumar R, Varadwaj P. Prediction of mutagenicity of compounds by support vector machine. Online J Bioinfo 2011; 12:9-17.
43. Bennett KP, Campbell C. Support vector machine: Hype or hallelujah? SIGKDD Explor 2000;2:1-13.
44. Chang CC, Lin CJ. LIBSVM: A library for support vector machines. 2001. Software Available from: http://www.csie.ntu.edu.tw/~cjlin/ libsvm. [cited in 2001].
45. Burton PS, Goodwin JT, Vidmar TJ, Amore BM. Predicting drug absorption: How nature made it a difficult problem. J Pharmacol Exp Ther 2002;303:889-95.
46. De Buck SS, Sinha VK, Fenu LA, Gilissen RA, Mackie CE, Nijsen M. The prediction of drug metabolism, tissue distribution and bioavailability of 50 structurally diverse compounds in rat using mechanism-based ADME prediction tools. Drug Metab Dispos 2007;35:649-59.
47. Ma CY, Yang SY, Zhang H, Xiang ML, Huang Q, Wei YQ, Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method. J Pharmaceut Biomed Anal 2008;47:677-82.